Publication | Open Access
Interplay between long noncoding RNA ZEB1-AS1 and miR-101/ZEB1 axis regulates proliferation and migration of colorectal cancer cells.
63
Citations
22
References
2018
Year
Crc CellsRna Zeb1-as1Cancer BiologyTumor BiologyTranscriptional RegulationOncologyCancer Cell BiologyLong Non-coding RnaRadiation OncologyCancer ResearchColorectal CancerCrc TissuesMir-101/zeb1 AxisMicrorna DetectionColorectal Cancer CellsCell BiologySystems BiologyMedicineNon-coding Rna
Long noncoding RNAs (lncRNAs) are dysregulated in many diseases. MicroRNA-101 (miR-101) functions as a tumor suppressor by directly targeting ZEB1 in various cancers. However, the potential mechanism of lncRNA ZEB1-AS1 and miR-101/ZEB1 axis in CRC remains unknown. In this study, we further investigated the potential interplay between miR-101/ZEB1 axis and lncRNA ZEB1-AS1 in colorectal cancer (CRC). Results showed that ZEB1-AS1 was upregulated in CRC tissues and cells. MiR-101 was downregulated in CRC tissues and negatively correlated with ZEB1-AS1 and ZEB1 expression levels in CRC. Functional experiments showed that, consistent with ZEB1-AS1 depletion, miR-101 overexpression and ZEB1 depletion inhibited the proliferation and migration of CRC cells. Overexpression of miR-101 partially abolished the effects of ZEB1-AS1 on the proliferation and migration of these cells. Moreover, combined ZEB1-AS1 depletion and miR-101 overexpression significantly inhibited cell proliferation and migration of the CRC cells. Hence, ZEB1-AS1 functioned as a molecular sponge for miR-101 and relieved the inhibition of ZEB1 caused by miR-101. This study revealed a novel regulatory mechanism between ZEB1-AS1 and miR-101/ZEB1 axis. The interplay between ZEB1-AS1 and miR-101/ZEB1 axis contributed to the proliferation and migration of CRC cells, and targeting this interplay could be a promising strategy for CRC treatment.
| Year | Citations | |
|---|---|---|
2016 | 17.9K | |
2010 | 5.2K | |
2017 | 3.8K | |
2011 | 714 | |
2006 | 469 | |
2015 | 274 | |
2015 | 267 | |
2008 | 242 | |
2017 | 166 | |
2016 | 129 |
Page 1
Page 1